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Paraneoplastic syndromes are caused by ectopic hormone production in malignant tumors. Hypercalcemia of malignancy is 
the main manifestation of paraneoplastic syndromes and can lead to acute kidney injury, life-threatening arrhythmia, and cardiac 
arrest. Here, we present a 70-year-old Asian female with a probable diagnosis of advanced lung cancer with hypercalcemia of 
malignancy. She underwent surgery to treat a pathologic fracture of the humerus. In this case, hypercalcemia of malignancy was 
unexpectedly aggravated after surgery, and hypercalcemic complications led to a poor outcome for the patient.
Abbreviations: HCM: Hypercalcemia of Malignancy; BPM: Beats Per Minute; ICU: Intensive Care Unit; AKI: Acute Kidney Injury; 
POD: Postoperative Day; PVC: Premature Ventricular Complexes; CRRT: A Continuous Renal Replacement Therapy; HHM: Humoral 
Hypercalcemia of Malignancy; IL: Interleukin; ECG: Electrocardiography; PTH: Parathyroid Hormone; PTHrP: Parathyroid Hormone-
related Peptide
Introduction
Paraneoplastic syndromes refer to a cluster of symptoms that 
result from malignancy but not attributed to direct tumor invasion 
or compression [1]. Paraneoplastic syndromes are caused by 
ectopic hormone production. Hypercalcemia develops due to an 
increase in parathyroid hormone. However, in cancer patients, it is 
mostly caused by paraneoplastic syndromes due to malignancy [2]. 
HCM occurs in more than 30% of patients with cancer, and 8.6% of 
them have bone metastases [3,4]. In HCM, the mortality rate is 50% 
within a month and 75% within three months of starting treatment 
[5]. Lung cancer is the most common cancer associated with HCM, 
observed in 12.5% of patients with advanced lung cancer [6]. In 
addition, the survival rate of patients with pathologic metastatic 
fractures is the lowest at 110 days for patients with lung cancer 
compared with those with other cancers [7]. The outcomes of HCM 
can range from mild symptoms to serious complications [2]. Mild 
symptoms include poor oral intake, general weakness, somnolence, 
constipation, anorexia, polyuria, and hypertension. Serious 
complications include psychosis, coma, renal failure, pancreatitis, 
life-threatening arrhythmia, and cardiac arrest. Here, we present 
a case of a 70-year-old woman with a probable diagnosis of lung 
cancer who underwent surgery for a pathologic fracture of the 
humerus.
Case Report
A 70-year-old woman (height, 160 cm; weight, 65 kg) was 
hospitalized for surgery at an orthopedic outpatient clinic with a 
fracture of the right humerus. The patient had a history of breast 
cancer, stroke, and patent foramen ovale (grade 1). The patient 
could climb two flights of stairs prior to the injury; however, she 
had bloody sputum for the past month and experienced dyspnea 
on exertion. Reduced breathing sound accompanied by crackle 
was auscultated in the right middle and right lower lobes. On non-
contrast chest computed tomography, a huge mass of around 10 
cm was observed in the right middle and right lower lobes with 
associated mucoid impaction and patchy ground-glass opacity, 
suggesting primary lung cancer. 
The patient underwent open reduction and internal 
fixation for the right humerus fracture. On the day of surgery, 
electrocardiography, pulse oximetry, continuous arterial blood 
pressure monitoring in the left radial artery, and tympanic 
temperature measurement were performed. Initially, her blood 
pressure was 127/76 mmHg, heart rate was 116 bpm, and SpO2 
was 95–97% with 7 L/min oxygen supplied by a nasal cannula. 
Regional anesthesia was performed with ultrasound-guided 
supraclavicular brachial plexus block using 0.75% ropivacaine 
(90 mg) and 2% lidocaine (240 mg). The initial corrected calcium 
Citation:  Eun Jang Yoon, Seungho Jung, Sungwon Na, Jiwoo Suh, Tae-Hwan Yoon, Jeongmin Kim*. A Rare Case of Aggravated Hypercalcemia 
of Malignancy After Surgery. Sur Cas Stud Op Acc J. 6(4)- 2021. SCSOAJ.MS.ID.000242. DOI: 10.32474/SCSOAJ.2021.06.000242.
                                                                                                                                                      Volume 6 - Issue 4   Copyrights @ Jeongmin Kim, et al.Sur Cas Stud Op Acc J
641
level was 13.4 mg/dL (3.35 mmol/L); thus, we started hydration 
to treat hypercalcemia (Figure 1). The operation was uneventful. 
Blood pressure was decreased at 15 min after the start of surgery. 
Norepinephrine was infused and increased to 0.06 μg/kg/min. 
Following norepinephrine infusion, blood pressure was well 
maintained during the operation, and the lowest blood pressure 
was 86/52(65) mmHg. After the surgery, she was admitted to the 
ICU for close monitoring.
Figure 1: Preoperative and postoperative corrected calcium levels: This graph shows changes in the corrected calcium levels 
over the course of hospital admission of the patient. The serum level of calcium was markedly increased immediately after the 
operation and was decreased following dialysis at 30 h after the operation. Mild hypercalcemia corresponds to a level of 10.5 
to 11.9 mg/dL, moderate hypercalcemia corresponds to a level of 12.0 to 13.9 mg/dL, and severe hypercalcemia corresponds 
to a level above 14.0 mg/dL [3]. *Ca: calcium, Preop: preoperative period, Postop: postoperative period.
The patient’s initial mental status was alert in the ICU but 
soon changed to drowsy, confused, and disoriented. The patient 
also complained of constant thirst at 3 h after admission to the 
ICU. Notably, the corrected calcium level was rapidly increased 
to 17.4 mg/dL (4.35 mmol/L), which is indicative of severe 
hypercalcemia (Figure 1). Other laboratory tests revealed newly 
onset AKI. Therefore, urine output was monitored, and 4 mL/kg/h 
plasma solution was administered to treat severe hypercalcemia 
and AKI. In addition, furosemide and zoledronic acid (4 mg/day) 
were administered. On POD 1, the corrected calcium level remained 
high at 16.2 mg/dL (4.0 mmol/L). On POD 2, sinus tachycardia 
with frequent PVCs and persistent hypercalcemia were noted; thus, 
CRRT was initiated. Hydration, medication, and CRRT normalized 
serum calcium levels. After CRRT, the mental status was improved 
to alert and partially disoriented. Frequent PVCs were no longer 
observed, and the body temperature was gradually decreased 
from 39℃ to 37.2℃. However, on POD 5, the general health status 
rapidly deteriorated. Atrial flutter was observed, and hypoxemia 
was aggravated; thus, mechanical ventilation had to be applied. The 
patient developed shock, including a high fever, which increased 
the demand for continuous norepinephrine administration (0.4 μg/
kg/min). One week after surgery, the patient suffered from cardiac 
arrest and deceased despite active medical intervention.
Discussion
Although several studies have examined the perioperative 
consideration of patients with hypercalcemia due to primary 
hyperparathyroidism, reports on patients with HCM are limited. 
This report highlighted the exacerbation of HCM after surgery. 
The mechanism of HCM is well known, which is secondary to the 
secretion of bioactive substances from neoplastic cells [2]. HHM 
accounts for 80% of the causes of HCM [3]. The etiological factor 
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for hypercalcemia in HHM is PTHrP, which is structurally similar 
to PTH. PTHrP causes the renal tubular reabsorption of calcium 
and, at the same time, increases urinary phosphorus excretion, 
leading to hypercalcemia and hypophosphatemia. Local osteolytic 
hypercalcemia accounts for 20% of the cases of cancer-related 
hypercalcemia and is usually associated with extensive bone 
metastases and skeletal tumor burden. In metastatic bone cancers, 
local cytokines such as IL-1, IL-3, IL-6, and tumor necrosis factor 
α are secreted, leading to excessive osteoclast activation. This 
increases resorption and promotes the local production of PTHrP, 
resulting in hypercalcemia. In this patient, the postoperative PTH 
level was as low as 11.7 pg/mL, and the level of PTHrP was increased 
to 31.3 pmol/L. The preoperative hypercalcemic state of this 
patient was characterized by the manifestation of paraneoplastic 
syndromes, which appear to have been caused by HHM due to 
suspected primary lung cancer or local osteolytic hypercalcemia 
resulting from bone metastasis.
Hypercalcemia was rapidly worsened after surgery. In the 
present case, the corrected serum calcium level before surgery was 
13.4 mg/dL (3.35 mmol/L) (moderate hypercalcemia); however, 
after the surgery, it was significantly increased to 17.4 mg/dL (4.35 
mmol/L) (severe hypercalcemia). HCM could be exacerbated after 
surgery for various reasons. Hypercalcemia may be worsened by 
immobilization and intraoperative hypotension. In addition, the 
operation itself may be an aggravating factor of hypercalcemia 
[8]. Surgery can cause an increase in plasma prostaglandin E2 and 
interleukin-6, leading to complex systemic reactions. After surgery, 
the high calcium levels in this patient could be attributed to the 
activation of osteoclasts due to cytokine secretion. Therefore, the 
possibility of postoperatively exacerbated hypercalcemia in cancer 
patients with paraneoplastic syndromes should be considered.
The perioperative management of HCM can be inferred from 
the management of hypercalcemia caused by hyperparathyroidism; 
however, there is limited information on the management of HCM. 
It is important to normalize blood calcium levels before surgery 
with normal saline, phosphate or furosemide, and bisphosphonates 
[9]. If dehydration and malnutrition are not corrected, hypotension 
or circulatory failure may occur with a high probability after 
anesthetic induction. Neuromuscular monitoring is necessary 
because it is difficult to predict the effects of neuromuscular 
blockers. Additionally, continuous ECG monitoring is required for 
the detection of changes in the cardiac rhythm. Hypotension should 
be avoided as it can lead to acidosis with an increase in ionized 
calcium [10]; thus, invasive arterial blood pressure monitoring can 
be beneficial.
Conclusion 
Surgery aggravates HCM and affects patient outcomes: thus, 
HCM should be corrected with bisphosphonate, furosemide, or 
dialysis before surgery to prevent complications. Tracking calcium 
levels, ECG monitoring, and neuromuscular monitoring during 
surgery are also crucial. As demonstrated in this case, healthcare 
providers should be aware that hypercalcemia could be aggravated 
during the postoperative period. Therefore, calcium levels should 
be closely monitored, and it is necessary to prepare for the 
management of the hypercalcemic state.
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